Structure

Physi-Chem Properties

Molecular Weight:  578.16
Volume:  534.737
LogP:  1.305
LogD:  0.277
LogS:  -4.19
# Rotatable Bonds:  7
TPSA:  221.9
# H-Bond Aceptor:  14
# H-Bond Donor:  7
# Rings:  5
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.163
Synthetic Accessibility Score:  4.672
Fsp3:  0.481
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.364
MDCK Permeability:  1.2487530511862133e-05
Pgp-inhibitor:  0.571
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.954
20% Bioavailability (F20%):  0.03
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.088
Plasma Protein Binding (PPB):  76.2105941772461%
Volume Distribution (VD):  0.651
Pgp-substrate:  8.068002700805664%

ADMET: Metabolism

CYP1A2-inhibitor:  0.071
CYP1A2-substrate:  0.094
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.008
CYP2C9-substrate:  0.047
CYP2D6-inhibitor:  0.017
CYP2D6-substrate:  0.137
CYP3A4-inhibitor:  0.117
CYP3A4-substrate:  0.11

ADMET: Excretion

Clearance (CL):  2.544
Half-life (T1/2):  0.504

ADMET: Toxicity

hERG Blockers:  0.314
Human Hepatotoxicity (H-HT):  0.114
Drug-inuced Liver Injury (DILI):  0.955
AMES Toxicity:  0.867
Rat Oral Acute Toxicity:  0.019
Maximum Recommended Daily Dose:  0.008
Skin Sensitization:  0.098
Carcinogencity:  0.483
Eye Corrosion:  0.003
Eye Irritation:  0.118
Respiratory Toxicity:  0.021

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475233

Natural Product ID:  NPC475233
Common Name*:   Physcion 8-O-Rhamnosyl-(1->2)-Glucoside
IUPAC Name:   1-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8-hydroxy-3-methoxy-6-methylanthracene-9,10-dione
Synonyms:  
Standard InCHIKey:  IODWPQMAPBGFAM-ZETRQFANSA-N
Standard InCHI:  InChI=1S/C27H30O14/c1-10-3-12-17(14(30)4-10)21(33)18-13(19(12)31)5-11(37-2)6-15(18)39-25-23(22(34)20(32)16(7-28)40-25)41-26-24(35)27(36,8-29)9-38-26/h3-6,16,20,22-26,28-30,32,34-36H,7-9H2,1-2H3/t16-,20-,22+,23-,24+,25-,26+,27-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2cc(OC)cc3c2C(=O)c2c(C3=O)cc(cc2O)C)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1OC[C@]([C@H]1O)(O)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL501523
PubChem CID:   44584613
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000018] Anthracenes
        • [CHEMONTID:0000151] Anthraquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33118 Rhamnus Genus Rhamnaceae Eukaryota n.a. n.a. n.a. PMID[8350094]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens ED50 = 3.58 ug ml-1 PMID[564092]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 2.5 ug ml-1 PMID[564092]
NPT20967 CELL-LINE Platelet n.a. Activity = 78.2 % PMID[564093]
NPT20967 CELL-LINE Platelet n.a. Activity = 75.9 % PMID[564093]
NPT20967 CELL-LINE Platelet n.a. Activity = 76.7 % PMID[564093]
NPT20967 CELL-LINE Platelet n.a. Activity = 86.6 % PMID[564093]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475233 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9877 High Similarity NPC98776
0.9816 High Similarity NPC30432
0.9816 High Similarity NPC111536
0.9816 High Similarity NPC271385
0.9816 High Similarity NPC76128
0.9816 High Similarity NPC5029
0.9697 High Similarity NPC68381
0.9639 High Similarity NPC46958
0.9639 High Similarity NPC475246
0.9578 High Similarity NPC3718
0.9573 High Similarity NPC222455
0.9524 High Similarity NPC153578
0.9524 High Similarity NPC114257
0.9524 High Similarity NPC277710
0.9524 High Similarity NPC299149
0.9524 High Similarity NPC212290
0.9515 High Similarity NPC298778
0.9467 High Similarity NPC475161
0.9467 High Similarity NPC477860
0.9461 High Similarity NPC146803
0.9455 High Similarity NPC473202
0.9455 High Similarity NPC259905
0.9451 High Similarity NPC178851
0.9401 High Similarity NPC472054
0.9353 High Similarity NPC315221
0.9345 High Similarity NPC474345
0.9302 High Similarity NPC87583
0.9298 High Similarity NPC313452
0.9286 High Similarity NPC85368
0.9286 High Similarity NPC213052
0.9286 High Similarity NPC199357
0.9268 High Similarity NPC212099
0.9268 High Similarity NPC146837
0.9268 High Similarity NPC278329
0.9268 High Similarity NPC101116
0.9264 High Similarity NPC470810
0.9249 High Similarity NPC105591
0.9231 High Similarity NPC470454
0.9231 High Similarity NPC199533
0.9157 High Similarity NPC478020
0.9157 High Similarity NPC478022
0.9157 High Similarity NPC178281
0.9152 High Similarity NPC216752
0.9118 High Similarity NPC63105
0.9107 High Similarity NPC191653
0.9085 High Similarity NPC470607
0.9075 High Similarity NPC473631
0.9075 High Similarity NPC475662
0.9075 High Similarity NPC293227
0.9075 High Similarity NPC473717
0.907 High Similarity NPC245059
0.907 High Similarity NPC84494
0.9064 High Similarity NPC324220
0.9064 High Similarity NPC312630
0.9059 High Similarity NPC203751
0.9053 High Similarity NPC212748
0.9036 High Similarity NPC93215
0.9034 High Similarity NPC314672
0.903 High Similarity NPC200708
0.903 High Similarity NPC472320
0.903 High Similarity NPC470358
0.9024 High Similarity NPC23817
0.9024 High Similarity NPC470606
0.9017 High Similarity NPC470453
0.9017 High Similarity NPC208069
0.9017 High Similarity NPC164047
0.9017 High Similarity NPC470452
0.9017 High Similarity NPC470448
0.9 High Similarity NPC235575
0.8982 High Similarity NPC471286
0.8982 High Similarity NPC183672
0.8971 High Similarity NPC221140
0.8971 High Similarity NPC229817
0.8971 High Similarity NPC475220
0.8971 High Similarity NPC473686
0.8971 High Similarity NPC475352
0.897 High Similarity NPC73511
0.8963 High Similarity NPC261866
0.8963 High Similarity NPC265480
0.8963 High Similarity NPC17521
0.8963 High Similarity NPC149368
0.8953 High Similarity NPC289876
0.8953 High Similarity NPC102053
0.8941 High Similarity NPC241874
0.8941 High Similarity NPC478021
0.8941 High Similarity NPC477573
0.8941 High Similarity NPC477571
0.8941 High Similarity NPC477572
0.8935 High Similarity NPC249977
0.8935 High Similarity NPC474024
0.8935 High Similarity NPC477502
0.8935 High Similarity NPC63470
0.8933 High Similarity NPC314459
0.8933 High Similarity NPC470199
0.8929 High Similarity NPC7752
0.8922 High Similarity NPC44947
0.8922 High Similarity NPC259834
0.8922 High Similarity NPC472402
0.8922 High Similarity NPC131745
0.8916 High Similarity NPC271479
0.8909 High Similarity NPC161749
0.8909 High Similarity NPC197896
0.8909 High Similarity NPC258035
0.8909 High Similarity NPC122809
0.8909 High Similarity NPC156457
0.8909 High Similarity NPC313163
0.8902 High Similarity NPC470604
0.8902 High Similarity NPC470603
0.8902 High Similarity NPC99233
0.8902 High Similarity NPC470605
0.8896 High Similarity NPC40356
0.8896 High Similarity NPC154683
0.8895 High Similarity NPC108202
0.8895 High Similarity NPC472607
0.8889 High Similarity NPC261254
0.8889 High Similarity NPC294501
0.8882 High Similarity NPC229687
0.8876 High Similarity NPC178173
0.8869 High Similarity NPC66087
0.8869 High Similarity NPC124155
0.8869 High Similarity NPC257566
0.8869 High Similarity NPC100849
0.8869 High Similarity NPC179198
0.8869 High Similarity NPC278419
0.8862 High Similarity NPC30655
0.8862 High Similarity NPC74854
0.8862 High Similarity NPC47923
0.8862 High Similarity NPC303913
0.8862 High Similarity NPC45124
0.8857 High Similarity NPC473883
0.8857 High Similarity NPC478001
0.8855 High Similarity NPC308265
0.8855 High Similarity NPC279732
0.8851 High Similarity NPC58538
0.8848 High Similarity NPC45165
0.8848 High Similarity NPC208152
0.8848 High Similarity NPC78492
0.8848 High Similarity NPC170475
0.8848 High Similarity NPC206378
0.8844 High Similarity NPC257714
0.8844 High Similarity NPC156635
0.8841 High Similarity NPC268950
0.8841 High Similarity NPC78021
0.8841 High Similarity NPC211158
0.8841 High Similarity NPC108706
0.8841 High Similarity NPC469405
0.8841 High Similarity NPC106625
0.8841 High Similarity NPC87304
0.8837 High Similarity NPC154986
0.8834 High Similarity NPC470569
0.8833 High Similarity NPC470198
0.8833 High Similarity NPC470193
0.8833 High Similarity NPC470196
0.8833 High Similarity NPC470195
0.8833 High Similarity NPC470194
0.8833 High Similarity NPC282474
0.8833 High Similarity NPC470200
0.8833 High Similarity NPC470197
0.8833 High Similarity NPC316274
0.883 High Similarity NPC287884
0.883 High Similarity NPC8704
0.883 High Similarity NPC44558
0.883 High Similarity NPC315306
0.883 High Similarity NPC76047
0.883 High Similarity NPC313717
0.883 High Similarity NPC150767
0.883 High Similarity NPC105511
0.883 High Similarity NPC224462
0.883 High Similarity NPC78734
0.8824 High Similarity NPC150131
0.8824 High Similarity NPC225419
0.8824 High Similarity NPC234497
0.8824 High Similarity NPC229729
0.8824 High Similarity NPC45400
0.8824 High Similarity NPC324522
0.8824 High Similarity NPC470341
0.8824 High Similarity NPC472058
0.8824 High Similarity NPC105414
0.8817 High Similarity NPC475979
0.8817 High Similarity NPC165720
0.8817 High Similarity NPC294722
0.881 High Similarity NPC473043
0.881 High Similarity NPC150164
0.881 High Similarity NPC127782
0.881 High Similarity NPC310603
0.881 High Similarity NPC300537
0.881 High Similarity NPC190450
0.881 High Similarity NPC125991
0.881 High Similarity NPC473961
0.8802 High Similarity NPC306978
0.8802 High Similarity NPC472055
0.8802 High Similarity NPC471976
0.8802 High Similarity NPC328093
0.88 High Similarity NPC53680
0.88 High Similarity NPC170203
0.88 High Similarity NPC85316
0.88 High Similarity NPC208797
0.88 High Similarity NPC197357
0.8795 High Similarity NPC208651
0.8795 High Similarity NPC206641

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475233 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8947 High Similarity NPD6559 Discontinued
0.8909 High Similarity NPD4381 Clinical (unspecified phase)
0.8824 High Similarity NPD3818 Discontinued
0.8814 High Similarity NPD7879 Clinical (unspecified phase)
0.8663 High Similarity NPD7804 Clinical (unspecified phase)
0.8639 High Similarity NPD6959 Discontinued
0.8613 High Similarity NPD7074 Phase 3
0.8555 High Similarity NPD7054 Approved
0.8545 High Similarity NPD4380 Phase 2
0.8523 High Similarity NPD8313 Approved
0.8523 High Similarity NPD8312 Approved
0.8506 High Similarity NPD7472 Approved
0.8478 Intermediate Similarity NPD6777 Approved
0.8478 Intermediate Similarity NPD6781 Approved
0.8478 Intermediate Similarity NPD6776 Approved
0.8478 Intermediate Similarity NPD6780 Approved
0.8478 Intermediate Similarity NPD6782 Approved
0.8478 Intermediate Similarity NPD6778 Approved
0.8478 Intermediate Similarity NPD6779 Approved
0.8457 Intermediate Similarity NPD6797 Phase 2
0.8409 Intermediate Similarity NPD7251 Discontinued
0.8393 Intermediate Similarity NPD7819 Suspended
0.8393 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8372 Intermediate Similarity NPD6232 Discontinued
0.8362 Intermediate Similarity NPD7808 Phase 3
0.8362 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8353 Intermediate Similarity NPD7075 Discontinued
0.8343 Intermediate Similarity NPD5844 Phase 1
0.8342 Intermediate Similarity NPD7435 Discontinued
0.8333 Intermediate Similarity NPD7473 Discontinued
0.8316 Intermediate Similarity NPD8151 Discontinued
0.8294 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD6166 Phase 2
0.8256 Intermediate Similarity NPD5494 Approved
0.8245 Intermediate Similarity NPD7697 Approved
0.8245 Intermediate Similarity NPD7696 Phase 3
0.8245 Intermediate Similarity NPD7698 Approved
0.8242 Intermediate Similarity NPD2532 Approved
0.8242 Intermediate Similarity NPD2534 Approved
0.8242 Intermediate Similarity NPD2533 Approved
0.8235 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD1934 Approved
0.8207 Intermediate Similarity NPD6534 Approved
0.8207 Intermediate Similarity NPD6535 Approved
0.8201 Intermediate Similarity NPD7871 Phase 2
0.8201 Intermediate Similarity NPD7870 Phase 2
0.8182 Intermediate Similarity NPD7228 Approved
0.8182 Intermediate Similarity NPD3751 Discontinued
0.8176 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8168 Intermediate Similarity NPD7701 Phase 2
0.8166 Intermediate Similarity NPD7411 Suspended
0.814 Intermediate Similarity NPD3749 Approved
0.8133 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8118 Intermediate Similarity NPD6801 Discontinued
0.8118 Intermediate Similarity NPD37 Approved
0.8095 Intermediate Similarity NPD6823 Phase 2
0.8092 Intermediate Similarity NPD6234 Discontinued
0.8083 Intermediate Similarity NPD7874 Approved
0.8083 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.8081 Intermediate Similarity NPD4966 Approved
0.8081 Intermediate Similarity NPD4967 Phase 2
0.8081 Intermediate Similarity NPD4965 Approved
0.8081 Intermediate Similarity NPD3882 Suspended
0.8075 Intermediate Similarity NPD7699 Phase 2
0.8075 Intermediate Similarity NPD7700 Phase 2
0.8047 Intermediate Similarity NPD3226 Approved
0.8041 Intermediate Similarity NPD7783 Phase 2
0.8041 Intermediate Similarity NPD7801 Approved
0.8041 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.8024 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD1549 Phase 2
0.7966 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD2801 Approved
0.7955 Intermediate Similarity NPD3787 Discontinued
0.7944 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7923 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD5402 Approved
0.7917 Intermediate Similarity NPD8320 Phase 1
0.7917 Intermediate Similarity NPD8319 Approved
0.7914 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD7199 Phase 2
0.7895 Intermediate Similarity NPD6599 Discontinued
0.7861 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD6213 Phase 3
0.7861 Intermediate Similarity NPD6212 Phase 3
0.7861 Intermediate Similarity NPD1465 Phase 2
0.7816 Intermediate Similarity NPD3817 Phase 2
0.7802 Intermediate Similarity NPD7240 Approved
0.7784 Intermediate Similarity NPD8150 Discontinued
0.7771 Intermediate Similarity NPD7768 Phase 2
0.7758 Intermediate Similarity NPD2796 Approved
0.7753 Intermediate Similarity NPD5710 Approved
0.7753 Intermediate Similarity NPD5711 Approved
0.7751 Intermediate Similarity NPD1511 Approved
0.7751 Intermediate Similarity NPD6799 Approved
0.7751 Intermediate Similarity NPD7390 Discontinued
0.7744 Intermediate Similarity NPD7584 Approved
0.7725 Intermediate Similarity NPD2800 Approved
0.7719 Intermediate Similarity NPD5403 Approved
0.7719 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD2346 Discontinued
0.7709 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD1510 Phase 2
0.7688 Intermediate Similarity NPD8434 Phase 2
0.7685 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD1607 Approved
0.7679 Intermediate Similarity NPD4628 Phase 3
0.7679 Intermediate Similarity NPD3750 Approved
0.7665 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD1512 Approved
0.7657 Intermediate Similarity NPD8455 Phase 2
0.763 Intermediate Similarity NPD7458 Discontinued
0.763 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD7685 Pre-registration
0.7602 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD5401 Approved
0.7585 Intermediate Similarity NPD8059 Phase 3
0.7585 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1240 Approved
0.7545 Intermediate Similarity NPD6099 Approved
0.7545 Intermediate Similarity NPD6100 Approved
0.7515 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6674 Discontinued
0.7514 Intermediate Similarity NPD3926 Phase 2
0.7514 Intermediate Similarity NPD920 Approved
0.75 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD5953 Discontinued
0.744 Intermediate Similarity NPD2935 Discontinued
0.744 Intermediate Similarity NPD1551 Phase 2
0.7412 Intermediate Similarity NPD1243 Approved
0.7403 Intermediate Similarity NPD1247 Approved
0.7399 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD2344 Approved
0.7389 Intermediate Similarity NPD7930 Approved
0.7389 Intermediate Similarity NPD919 Approved
0.7385 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD3748 Approved
0.738 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD1653 Approved
0.7371 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD7229 Phase 3
0.735 Intermediate Similarity NPD7585 Approved
0.7347 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD7583 Approved
0.7299 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD8285 Discontinued
0.7283 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD2799 Discontinued
0.7273 Intermediate Similarity NPD4625 Phase 3
0.7263 Intermediate Similarity NPD5761 Phase 2
0.7263 Intermediate Similarity NPD5760 Phase 2
0.7258 Intermediate Similarity NPD7286 Phase 2
0.7257 Intermediate Similarity NPD6273 Approved
0.724 Intermediate Similarity NPD4287 Approved
0.7236 Intermediate Similarity NPD7680 Approved
0.7235 Intermediate Similarity NPD5404 Approved
0.7235 Intermediate Similarity NPD5405 Approved
0.7235 Intermediate Similarity NPD5406 Approved
0.7235 Intermediate Similarity NPD5408 Approved
0.7229 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD2309 Approved
0.7179 Intermediate Similarity NPD4363 Phase 3
0.7179 Intermediate Similarity NPD4360 Phase 2
0.7177 Intermediate Similarity NPD8366 Approved
0.7164 Intermediate Similarity NPD7999 Approved
0.716 Intermediate Similarity NPD6651 Approved
0.7143 Intermediate Similarity NPD943 Approved
0.7143 Intermediate Similarity NPD1613 Approved
0.7143 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD1470 Approved
0.7126 Intermediate Similarity NPD6190 Approved
0.7126 Intermediate Similarity NPD3764 Approved
0.7126 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD2313 Discontinued
0.712 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7112 Intermediate Similarity NPD7177 Discontinued
0.7112 Intermediate Similarity NPD7799 Discontinued
0.7112 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD4908 Phase 1
0.7104 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD230 Phase 1
0.7093 Intermediate Similarity NPD7266 Discontinued
0.7093 Intermediate Similarity NPD1471 Phase 3
0.7076 Intermediate Similarity NPD7033 Discontinued
0.7069 Intermediate Similarity NPD7003 Approved
0.7052 Intermediate Similarity NPD2424 Discontinued
0.7042 Intermediate Similarity NPD8491 Approved
0.7028 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD8127 Discontinued
0.7024 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD6410 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data